Zobrazeno 1 - 10
of 31
pro vyhledávání: '"Dennis A. Wigle"'
Autor:
Fang-Shu Ou, Tsung Teh Wu, Brenda Ginos, Harry H. Yoon, Timothy F. Drevyanko, Steven R. Alberts, Maged F. Khalil, Gamini S. Soori, Robert J. Behrens, Dennis A. Wigle, Stephen J. Ko, Daniel A. Nikcevich, Robert C. Miller, George P. Kim, Qian Shi, James L. Leenstra, Patrick J. Peller, Robert P. Sticca, Erica N. Heying, Bassam I. Mattar
Publikováno v:
Eur J Cancer
Aim report primary results from the first multicentre randomised trial evaluating induction chemotherapy prior to trimodality therapy in patients with oesophageal or gastro-oesophageal junction adenocarcinoma. Notably, recent data from a single-insti
Autor:
Yolanda I. Garces, Aaron S. Mansfield, Christopher L. Hallemeier, Kenneth W. Merrell, Dennis A. Wigle, Kenneth R. Olivier, Sean S. Park, BA William G. Breen
Publikováno v:
Advances in Radiation Oncology, Vol 2, Iss 1, Pp 12-18 (2017)
Advances in Radiation Oncology
Advances in Radiation Oncology
Purpose For patients with stage III (N2) non–small cell lung cancer (NSCLC) treated with surgical resection, postoperative chemotherapy improves overall survival (OS), but the role of postoperative radiation therapy (PORT) is controversial. The pur
Autor:
Francis C. Nichols, Shanda H. Blackmon, K. Robert Shen, William S. Harmsen, Matthew L. Inra, Jim Taswell, Mark S. Allen, Sahar A. Saddoughi, Stephen D. Cassivi, Dennis A. Wigle
Publikováno v:
The Annals of Thoracic Surgery. 101:311-315
Background Although surgical resection of adenocarcinoma or squamous cell carcinoma of the esophagus is standard practice, the treatment strategy for other malignant rare esophageal cancers is still under debate. The aim of this study was to examine
Autor:
Simone Terra, Dennis A. Wigle, Tobias Peikert, Charlie T. Seto, Faye R. Harris, Sarah H. Johnson, Joema Felipe Lima, Stephen J. Murphy, Marie Christine Aubry, George Vasmatzis, Michael K. Asiedu, Ping Yang, Geoffrey C. Halling, Farhad Kosari
Publikováno v:
Cancer Research. 74:3157-3167
The development of adenocarcinoma of the lung is believed to proceed from in situ disease (adenocarcinoma in situ, AIS) to minimally invasive disease with prominent lepidic growth (minimally invasive adenocarcinoma, MIA), then to fully invasive adeno
Publikováno v:
The Annals of Thoracic Surgery. 97:1459-1463
Postesophagectomy anastomotic leaks cause significant morbidity and mortality. Esophageal diversion is often required when extensive tissue loss precludes primary repair. We describe a technique in which human acellular dermis (AlloDerm) is used to r
Autor:
Farhad Kosari, Dennis A. Wigle, Stephen J. Murphy, Marie Christine Aubry, Sandra C. Tomaszek, Cristiane M. Ida, Sibel Erdogan, L. C. Bolette, Janet L. Schaefer Klein, Irina V. Kovtun, Ping Yang, C. P. Kolbert, Lin Yang, Yafei Li, George Vasmatzis
Publikováno v:
Oncogene. 33:3776-3783
ASCL1 is an important regulatory transcription factor in pulmonary neuroendocrine (NE) cell development, but its value as a biomarker of NE differentiation in lung adenocarcinoma (AD) and as a potential prognostic biomarker remains unclear. We examin
Publikováno v:
Journal of Thoracic Oncology. 13:S442
Autor:
Mark S. Allen, Dennis A. Wigle, Masatsugu Hamaji, Claude Deschamps, K. Robert Shen, Stephen D. Cassivi, Francis C. Nichols
Publikováno v:
The Annals of Thoracic Surgery. 94:1796-1800
Background The aim of this study was to clarify the clinical outcome and significance of mediastinal lymph node dissection (LND) during pulmonary resection of metastases from colorectal adenocarcinoma. Methods A retrospective chart review was perform
Autor:
Dennis A. Wigle, Karen J. Dickinson, Francis C. Nichols, Lizhi Zhang, Stephen D. Cassivi, Mark S. Allen, Shanda H. Blackmon, Kenneth K. Wang, Robert Shen
Publikováno v:
The Annals of thoracic surgery. 103(3)
Background Endoscopic mucosal resection (EMR) and esophagectomy are treatment options for cT1 esophageal adenocarcinoma. Our aim was to study outcomes for patients undergoing EMR then esophagectomy. Methods We identified patients undergoing EMR and e
Autor:
Kristin C. Mara, K. Robert Shen, Mark S. Allen, S. William Harmsen, Sahar A. Saddoughi, Dennis A. Wigle, James Taswell, Stephen D. Cassivi, J. Matthew Reinersman, Yuriy O. Zhukov, Francis C. Nichols, Shanda H. Blackmon
Publikováno v:
The Annals of thoracic surgery. 103(1)
Background Five-year survival of stage IV esophageal cancer is rare. The treatment of advanced esophageal cancer is typically palliative and the role of surgery remains controversial. We sought to understand the impact of curative surgery on survival